Navarro F - Search Results

1

Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae.

Rodríguez-Navarro J, Miró E, Brown-Jaque M, Hurtado JC, Moreno A, Muniesa M, González-López JJ, Vila J, Espinal P, Navarro F. Rodríguez-Navarro J, et al. Among authors: navarro f. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02064-19. doi: 10.1128/AAC.02064-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32122890 Free PMC article.

2

[Resistance to imipenem in Enterobacter aerogenes].

Miró E, Alonso C, Navarro F, Mirelis B, Prats G. Miró E, et al. Among authors: navarro f. Enferm Infecc Microbiol Clin. 1995 May;13(5):278-82. Enferm Infecc Microbiol Clin. 1995. PMID: 7779892 Spanish.

3

In-vitro activity of E-4695, a new fluoronaphthyridine antimicrobial agent.

Mirelis B, Miró E, Navarro F, Prats G. Mirelis B, et al. Among authors: navarro f. J Antimicrob Chemother. 1994 May;33(5):1017-23. doi: 10.1093/jac/33.5.1017. J Antimicrob Chemother. 1994. PMID: 8089047 No abstract available.

4

Campylobacter spp antibiotic susceptibility.

Navarro F, Miró E, Mirelis B, Prats G. Navarro F, et al. J Antimicrob Chemother. 1993 Dec;32(6):906-7. doi: 10.1093/jac/32.6.906. J Antimicrob Chemother. 1993. PMID: 8144435 No abstract available.

5

Increased resistance to quinolone in Catalonia, Spain.

Mirelis B, Miro E, Navarro F, Ogalla CA, Bonal J, Prats G. Mirelis B, et al. Among authors: navarro f. Diagn Microbiol Infect Dis. 1993 Feb;16(2):137-9. doi: 10.1016/0732-8893(93)90009-v. Diagn Microbiol Infect Dis. 1993. PMID: 8467626

6

In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.

Mirelis B, Navarro F, Miró E, Coll R, Xicota MA, Prats G. Mirelis B, et al. Among authors: navarro f. Drugs Exp Clin Res. 1995;21(4):129-38. Drugs Exp Clin Res. 1995. PMID: 8529525

7

[Clinical relevance of gram-negative bacteria having inducible chromosomic beta-lactamase at an intensive care unit].

Navarro F, Alonso C, Ballús J, Miró E, March F, Coll P, Mirelis B. Navarro F, et al. Enferm Infecc Microbiol Clin. 1996 Mar;14(3):171-6. Enferm Infecc Microbiol Clin. 1996. PMID: 8695687 Spanish.

8

[Detection of resistance to the amoxicillin-clavulamic acid combination in Salmonella and Shigella].

Miró E, Mirelis B, Navarro F, Prats G. Miró E, et al. Among authors: navarro f. Enferm Infecc Microbiol Clin. 1996 Jan;14(1):31-3. Enferm Infecc Microbiol Clin. 1996. PMID: 8714185 Spanish.

9

Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.

Miró E, del Cuerpo M, Navarro F, Sabaté M, Mirelis B, Prats G. Miró E, et al. Among authors: navarro f. J Antimicrob Chemother. 1998 Oct;42(4):535-8. doi: 10.1093/jac/42.4.535. J Antimicrob Chemother. 1998. PMID: 9818756

10

Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacin.

Vila J, Ruiz J, Sanchez F, Navarro F, Mirelis B, de Anta MT, Prats G. Vila J, et al. Among authors: navarro f. Antimicrob Agents Chemother. 1999 Jan;43(1):161-2. doi: 10.1128/AAC.43.1.161. Antimicrob Agents Chemother. 1999. PMID: 9869583 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,029 results

Search Page